Dividend
-
-
-
-
-
-
-
Unicycive Announces Second Quarter 2024 Financial Results and Provides Business Update
-
-
-
-
-
-
-
Unicycive Therapeutics, Inc (UNCY) Enters Up to $130M Financing to Commercialize and Launch Investigational New Drug Renazorb
-
444,821 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

